ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $130,132,002.24

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$189.90

▲ +2.05 (1.09%)

As of 10/28/2024 11:54 AM ET

Days: 30 | 90 | 365

“Buffett Indicator” Predicts 62% Stock Market Crash

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2024	Richard A. Gonzalez	Chairman	Sell	66,500	$186.52	$12,403,580.00	446,599
7/17/2024	Richard A. Gonzalez	Chairman	Sell	282,845	$175.00	$49,497,875.00	513,099
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32
12/20/2021	Brian L. Durkin	VP	Sell	11,790	$128.51	$1,515,132.90
12/17/2021	Laura J. Schumacher	Vice Chairman	Sell	181,670	$130.24	$23,660,700.80
12/15/2021	Jeffrey Ryan Stewart	EVP	Sell	2,152	$128.00	$275,456.00
12/13/2021	Elaine K. Sorg	SVP	Sell	6,458	$125.85	$812,739.30
12/9/2021	Richard A. Gonzalez	CEO	Sell	174,100	$123.23	$21,454,343.00
12/6/2021	Timothy J. Richmond	EVP	Sell	50,350	$120.00	$6,042,000.00
11/2/2021	Roxanne S. Austin	Director	Sell	51,844	$116.38	$6,033,604.72

Central banks prepare for America’s Breaking Point

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/28/2024	Congress Asset Management Co.	96,329	$19.02M	0.1%	-0.6%	0.005%
10/28/2024	Nikulski Financial Inc.	37,806	$7.47M	2.2%	+0.7%	0.002%
10/28/2024	HM Payson & Co.	578,416	$114.23M	2.0%	+1.5%	0.033%
10/28/2024	Sippican Capital Advisors	14,790	$2.92M	2.0%	-4.3%	0.001%
10/28/2024	Bank Hapoalim BM	19,445	$3.84M	0.6%	-2.6%	0.001%
10/28/2024	Measured Wealth Private Client Group LLC	3,249	$0.64M	0.2%	-26.3%	0.000%
10/28/2024	Catalyst Financial Partners LLC	12,469	$2.46M	0.5%	+1.4%	0.001%
10/28/2024	Goldstone Financial Group LLC	8,749	$1.73M	0.3%	N/A	0.000%
10/25/2024	Voisard Asset Management Group Inc.	536	$0.11M	0.0%	+13.6%	0.000%
10/25/2024	Financial Advocates Investment Management	28,907	$5.71M	0.3%	+0.7%	0.002%
10/25/2024	1620 Investment Advisors Inc.	7,564	$1.49M	1.1%	-9.5%	0.000%
10/25/2024	Folger Nolan Fleming Douglas Capital Management Inc.	14,625	$2.89M	0.3%	-1.5%	0.001%
10/25/2024	Solidarity Wealth LLC	4,423	$0.87M	0.2%	-15.7%	0.000%
10/25/2024	Cornerstone Wealth Group LLC	67,657	$13.36M	1.1%	+0.2%	0.004%
10/25/2024	TNF LLC	1,510	$0.29M	0.1%	-10.2%	0.000%
10/25/2024	Oak Harvest Investment Services	38,001	$7.50M	1.1%	-1.0%	0.002%
10/25/2024	Hudson Valley Investment Advisors Inc. ADV	57,374	$11.33M	1.3%	+8.9%	0.003%
10/25/2024	Fiducient Advisors LLC	4,514	$0.89M	0.1%	+1.6%	0.000%
10/25/2024	JFS Wealth Advisors LLC	10,182	$2.01M	0.1%	+569.4%	0.001%
10/25/2024	SteelPeak Wealth LLC	16,935	$3.34M	0.1%	-50.1%	0.001%
10/25/2024	Sunburst Financial Group LLC	2,259	$0.45M	0.1%	-8.1%	0.000%
10/25/2024	Diversify Wealth Management LLC	15,795	$2.97M	0.3%	+17.3%	0.001%
10/25/2024	Pinnacle Associates Ltd.	123,638	$24.42M	0.4%	+4.8%	0.007%
10/25/2024	First Trust Direct Indexing L.P.	45,538	$8.99M	0.5%	+11.2%	0.003%
10/25/2024	WASHINGTON TRUST Co	30,016	$5.93M	0.2%	-2.0%	0.002%
10/25/2024	Capstone Triton Financial Group LLC	7,885	$1.56M	1.0%	-2.5%	0.000%
10/25/2024	New York State Teachers Retirement System	1,669,568	$329.71M	0.7%	-3.7%	0.095%
10/25/2024	Twin Peaks Wealth Advisors LLC	2,540	$0.50M	0.2%	+11.7%	0.000%
10/25/2024	Edge Financial Advisors LLC	2,941	$0.58M	0.5%	N/A	0.000%
10/25/2024	Loring Wolcott & Coolidge Fiduciary Advisors LLP MA	60,076	$11.39M	0.1%	+0.1%	0.003%
10/25/2024	GSB Wealth Management LLC	6,896	$1.36M	0.3%	+22.6%	0.000%
10/25/2024	Trajan Wealth LLC	28,810	$5.69M	0.3%	-1.5%	0.002%
10/25/2024	Adams Diversified Equity Fund Inc.	199,000	$39.30M	1.4%	-10.4%	0.011%
10/25/2024	Pathway Financial Advisers LLC	32,679	$6.45M	0.1%	-0.7%	0.002%
10/25/2024	Mutual Advisors LLC	40,387	$7.66M	0.2%	-1.3%	0.002%
10/25/2024	Great Diamond Partners LLC	8,452	$1.67M	0.4%	-16.8%	0.000%
10/25/2024	Adell Harriman & Carpenter Inc.	171,741	$33.92M	2.5%	+0.5%	0.010%
10/25/2024	Avitas Wealth Management LLC	19,818	$3.91M	0.6%	-18.6%	0.001%
10/25/2024	Childress Capital Advisors LLC	6,623	$1.31M	0.4%	+1.9%	0.000%
10/25/2024	Highview Capital Management LLC DE	5,133	$1.01M	0.4%	+4.4%	0.000%
10/25/2024	Vanguard Capital Wealth Advisors	3,713	$0.73M	0.8%	-14.7%	0.000%
10/25/2024	Jacobsen Capital Management	3,148	$0.62M	0.3%	+17.6%	0.000%
10/25/2024	Fidelis Capital Partners LLC	24,745	$4.65M	0.5%	+7.7%	0.001%
10/25/2024	Valmark Advisers Inc.	7,483	$1.48M	0.0%	+13.5%	0.000%
10/25/2024	American Financial Advisors LLC	2,240	$0.44M	0.1%	-4.1%	0.000%
10/25/2024	GW Henssler & Associates Ltd.	1,295	$0.26M	0.0%	-38.1%	0.000%
10/25/2024	PBMares Wealth Management LLC	2,380	$0.47M	0.1%	+26.7%	0.000%
10/25/2024	Strategic Blueprint LLC	10,104	$2M	0.1%	-10.9%	0.001%
10/25/2024	Abich Financial Wealth Management LLC	689	$0.14M	0.3%	-44.4%	0.000%
10/25/2024	Caldwell Sutter Capital Inc.	5,541	$1.09M	0.5%	-3.5%	0.000%
10/25/2024	Farmers & Merchants Investments Inc.	91,090	$17.99M	0.6%	+1.4%	0.005%
10/25/2024	Cutter & CO Brokerage Inc.	7,306	$1.44M	0.3%	-1.2%	0.000%
10/25/2024	MONECO Advisors LLC	14,494	$2.86M	0.4%	+6.1%	0.001%
10/25/2024	Diversify Advisory Services LLC	24,577	$4.64M	0.2%	-14.6%	0.001%
10/25/2024	Integrated Advisors Network LLC	42,394	$8.37M	0.4%	-6.2%	0.002%
10/25/2024	Fortitude Family Office LLC	10,259	$2.03M	0.8%	+150.4%	0.001%
10/25/2024	Gateway Wealth Partners LLC	2,786	$0.55M	0.2%	+3.1%	0.000%
10/25/2024	Wells Trecaso Financial Group LLC	8,814	$1.74M	0.6%	-5.7%	0.000%
10/25/2024	Barry Investment Advisors LLC	1,955	$0.39M	0.1%	-4.1%	0.000%
10/25/2024	China Universal Asset Management Co. Ltd.	6,345	$1.25M	0.1%	+131.4%	0.000%
10/25/2024	Boston Financial Mangement LLC	31,608	$6.24M	0.2%	+4.2%	0.002%
10/25/2024	Traynor Capital Management Inc.	5,625	$1.11M	0.1%	+17.5%	0.000%
10/25/2024	abrdn plc	1,986,664	$389.22M	0.7%	-3.1%	0.113%
10/25/2024	Cantor Fitzgerald Investment Advisors L.P.	4,328	$0.86M	0.1%	N/A	0.000%
10/25/2024	Smith Group Asset Management LLC	4,170	$0.82M	0.1%	+1.5%	0.000%
10/25/2024	Worth Financial Advisory Group LLC	3,280	$0.65M	0.4%	+4.9%	0.000%
10/25/2024	Pallas Capital Advisors LLC	30,100	$5.71M	0.2%	-1.0%	0.002%
10/24/2024	Hunter Associates Investment Management LLC	23,855	$4.71M	0.7%	-1.7%	0.001%
10/24/2024	Strategic Wealth Investment Group LLC	50,917	$10.03M	1.1%	+34.6%	0.003%
10/24/2024	Orrstown Financial Services Inc.	5,122	$1.01M	0.3%	N/A	0.000%
10/24/2024	Old Port Advisors	1,126	$0.22M	0.1%	N/A	0.000%
10/24/2024	Autumn Glory Partners LLC	12,488	$2.47M	0.9%	+30.3%	0.001%
10/24/2024	Nisa Investment Advisors LLC	567,226	$112.02M	0.7%	+3.4%	0.032%
10/24/2024	TCI Wealth Advisors Inc.	16,285	$3.22M	0.3%	-0.5%	0.001%
10/24/2024	TCP Asset Management LLC	1,226	$0.24M	0.1%	N/A	0.000%
10/24/2024	Concord Wealth Partners	27,072	$5.35M	0.9%	+5.3%	0.002%
10/24/2024	Asahi Life Asset Management CO. LTD.	4,200	$0.83M	0.5%	-22.9%	0.000%
10/24/2024	Washburn Capital Management Inc.	5,179	$1.02M	0.7%	-1.0%	0.000%
10/24/2024	Welch Group LLC	360,199	$71.13M	3.1%	+0.2%	0.020%
10/24/2024	Inscription Capital LLC	18,786	$3.71M	0.6%	-0.8%	0.001%
10/24/2024	Smithbridge Asset Management Inc. DE	44,741	$8.84M	1.5%	+0.6%	0.003%
10/24/2024	Southern Capital Advisors LLC	1,191	$0.24M	0.1%	N/A	0.000%
10/24/2024	Gemmer Asset Management LLC	2,510	$0.50M	0.0%	-4.1%	0.000%
10/24/2024	Baker Tilly Wealth Management LLC	3,796	$0.75M	0.3%	-24.9%	0.000%
10/24/2024	FCG Investment Co	11,651	$2.30M	1.5%	+56.7%	0.001%
10/24/2024	Greenspring Advisors LLC	2,586	$0.51M	0.1%	N/A	0.000%
10/24/2024	Insight Folios Inc	42,313	$8.36M	3.0%	+4.8%	0.002%
10/24/2024	IVC Wealth Advisors LLC	1,537	$0.30M	0.2%	-4.0%	0.000%
10/24/2024	First American Bank	117,637	$23.23M	1.7%	-2.2%	0.007%
10/24/2024	Salomon & Ludwin LLC	4,786	$0.95M	0.1%	-2.0%	0.000%
10/24/2024	Peterson Wealth Advisors LLC	4,209	$0.83M	0.2%	+5.0%	0.000%
10/24/2024	First Financial Bankshares Inc	6,866	$1.36M	0.0%	-3.3%	0.000%
10/24/2024	Motiv8 Investments LLC	5,499	$1.09M	0.7%	+11.7%	0.000%
10/24/2024	OMNI 360 Wealth Inc.	3,048	$0.60M	0.4%	+3.4%	0.000%
10/24/2024	J.W. Cole Advisors Inc.	39,143	$7.73M	0.3%	+6.2%	0.002%
10/24/2024	Ellis Investment Partners LLC	7,296	$1.44M	0.3%	-13.5%	0.000%
10/24/2024	Essex Financial Services Inc.	37,704	$7.12M	0.3%	-0.5%	0.002%
10/24/2024	Fortune Financial Advisors LLC	1,039	$0.21M	0.2%	N/A	0.000%
10/24/2024	State of Alaska Department of Revenue	299,734	$59.19M	0.6%	-3.8%	0.017%
10/24/2024	Carret Asset Management LLC	50,759	$10.02M	1.1%	-2.0%	0.003%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $189.90

$187.52

$189.92

50 Day Range

MA: $194.02

$186.62

$199.35

52 Week Range

Now: $189.90

$135.85

$199.95

Volume

575,300 shs

Average Volume

5,265,257 shs

Market Capitalization

$335.34 billion

P/E Ratio

63.30

Dividend Yield

3.27%

Beta

0.63

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Timothy J Richmond (EVP)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
International Assets Investment Management LLC — 0.27%
Raymond James & Associates — 0.26%
DekaBank Deutsche Girozentrale — 0.17%
Swedbank AB — 0.12%
Assenagon Asset Management S.A. — 0.12%
abrdn plc — 0.11%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Artemis Investment Management LLP
DekaBank Deutsche Girozentrale
Simplicity Wealth LLC
Argent Capital Management LLC
Exchange Traded Concepts LLC
Bleakley Financial Group LLC
Allspring Global Investments Holdings LLC
New York State Teachers Retirement System
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
International Assets Investment Management LLC
Assenagon Asset Management S.A.
Eastern Bank
Hamlin Capital Management LLC
Foster Victor Wealth Advisors LLC
Guinness Asset Management LTD
AMF Tjanstepension AB
Creative Planning